🔴 Jasper Therapeutics is trading 5.16% down in pre-market as catalyst remains unclear

Jasper Therapeutics is trading at $0.65 (-5.16%) before the September 4, 2026 open, with no clear company-specific catalyst identified.

• The investor-relations page lists the latest release as August 14, 2026, concerning second-quarter results and a corporate update, rather than a September 4 announcement.
• Broader markets are mixed but generally firm, so macro sentiment does not clearly explain the decline.
• Catalyst remains unclear; monitoring is warranted.